Substance / Medication

Lurasidone hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Degradation studies on lurasidone hydrochloride using validated reverse phase HPLC and LC-MS/MS.
Kadam Tanvi, Agarwal Surendra, Shetty Saritha · Xenobiotica · 2025
PMID: 40304169Other
Assessment of Nitrosamine Impurities in Lurasidone Hydrochloride Using APCI-LC-MS/MS in MRM Mode for Regulatory Compliance and Stability Evaluation.
Yadav Anant D, Alaspure Ashish C, Bhavsar Pinal S et al. · Rapid Commun Mass Spectrom · 2025
PMID: 40851372Other
Separation and characterization of related substances of Lurasidone hydrochloride by LC-QTOF-MS techniques.
Siddig Orwa, Liu Chenxi, Abdulbagi Mohamed et al. · J Pharm Biomed Anal · 2024
PMID: 37948773Other
Improving Lurasidone Hydrochloride's Solubility and Stability by Higher-Order Complex Formation with Hydroxypropyl-β-cyclodextrin.
Gamboa-Arancibia María Elena, Caro Nelson, Gamboa Alexander et al. · Pharmaceutics · 2023
PMID: 36678861OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Lurasidone hydrochloride (substance)
SNOMED CT
703116009
UMLS CUI
C2697950

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

4
Conditions
3
Biomarkers
1
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.